⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for idiopathic myelofibrosis

Every month we try and update this database with for idiopathic myelofibrosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid TumorsNCT02440685
Lymphoma, Large...
Lymphoma, Mantl...
Lymphoma, Folli...
Cancer
Neoplasm
Tumor
Lymphoma, Malig...
Lymphoma, B-cel...
Lymphoma, Non-H...
B-Cell Chronic ...
B-Cell Leukemia...
B-Lymphocytic L...
Chronic Lymphoc...
Leukemia, Lymph...
Leukemia, Lymph...
Myelofibrosis
Chronic Idiopat...
Idiopathic Myel...
Lymphoma, T Cel...
Peripheral T-Ce...
T-Cell Lymphoma...
ASN002 Dose Esc...
ASN002 RD
18 Years - Asana BioSciences
Familial Myeloproliferative DisordersNCT00666289
Polycythemia Ve...
Essential Throm...
Idiopathic Myel...
7 Years - Icahn School of Medicine at Mount Sinai
Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic SyndromeNCT00475020
Myelofibrosis
Busulfan
Fludarabine
Thymoglobulin (...
- 75 YearsM.D. Anderson Cancer Center
Correlative Biomarker Study in Patients With Myeloproliferative DisordersNCT00665067
Myeloproliferat...
Myelofibrosis
Idiopathic Myel...
Essential Throm...
Polycythemia Ve...
18 Years - Icahn School of Medicine at Mount Sinai
Correlative Biomarker Study in Patients With Myeloproliferative DisordersNCT00665067
Myeloproliferat...
Myelofibrosis
Idiopathic Myel...
Essential Throm...
Polycythemia Ve...
18 Years - Icahn School of Medicine at Mount Sinai
Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosisNCT01433445
Idiopathic Myel...
Post Essential ...
Post Polycythem...
panobinostat
ruxolitinib
18 Years - Novartis
Research Tissue BankNCT00666549
Myelofibrosis
Idiopathic Myel...
Essential Throm...
Polycythemia Ve...
18 Years - Icahn School of Medicine at Mount Sinai
Molecular Changes and Biomarkers in Chronic Myeloproliferative DisordersNCT00433862
Polycythemia Ve...
Essential Throm...
Idiopathic Myel...
Neutrophils
Chronic Myelopr...
18 Years - National Institutes of Health Clinical Center (CC)
Familial Myeloproliferative DisordersNCT00666289
Polycythemia Ve...
Essential Throm...
Idiopathic Myel...
7 Years - Icahn School of Medicine at Mount Sinai
Molecular Changes and Biomarkers in Chronic Myeloproliferative DisordersNCT00433862
Polycythemia Ve...
Essential Throm...
Idiopathic Myel...
Neutrophils
Chronic Myelopr...
18 Years - National Institutes of Health Clinical Center (CC)
Research Tissue BankNCT00666549
Myelofibrosis
Idiopathic Myel...
Essential Throm...
Polycythemia Ve...
18 Years - Icahn School of Medicine at Mount Sinai
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: